CEO, Board Member
2023-01-01–present
Board Member
TerrAscend Corp. (TSNDF)Board Member
Heron Therapeutics, Inc. /De/ (HRTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2023-01-01–present
Recorded roles and earnings-call appearances connecting this person to public companies.
CEO, Board Member
2023-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Heron Therapeutics, Inc. /De/ (HRTX) | Chief Executive Officer | $689,431 | $3,516,291 |
| 2024 | Heron Therapeutics, Inc. /De/ (HRTX) | Chief Executive Officer | $515,000 | $1,424,811 |
| 2023 | Heron Therapeutics, Inc. /De/ (HRTX) | Chief Executive Officer | $492,986 | $10,775,818 |
| 2022 | Heron Therapeutics, Inc. /De/ (HRTX) | Chief Executive Officer | — | — |
Earnings-call appearances and filed executive appointments or departures, newest first.